UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Structure‐function relationships in thrombin‐activatable fibrinolysis inhibitor

Journal of thrombosis and haemostasis, 2016-04, Vol.14 (4), p.633-644

2016

Volltextzugriff (PDF)

Review: Viral infections and mechanisms of thrombosis and bleeding

Journal of medical virology, 2012-10, Vol.84 (10), p.1680-1696

2012

Volltextzugriff (PDF)

Hyperglycemia: a prothrombotic factor?

Journal of thrombosis and haemostasis, 2010-08, Vol.8 (8), p.1663-1669

2010

Volltextzugriff (PDF)

Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease

Haematologica (Roma), 2009-11, Vol.94 (11), p.1513-1519

2009

Volltextzugriff (PDF)

In vivo increase in thrombin generation by four‐factor prothrombin complex concentrate in apixaban‐treated healthy volunteers

Journal of thrombosis and haemostasis, 2015-10, Vol.13 (10), p.1799-1805

2015

Volltextzugriff (PDF)

Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure

Journal of thrombosis and haemostasis, 2012-07, Vol.10 (7), p.1312-1319

2012

Volltextzugriff (PDF)

Factor XI promotes hemostasis in factor IX‐deficient mice

Journal of thrombosis and haemostasis, 2018-10, Vol.16 (10), p.2044-2049

2018

Volltextzugriff (PDF)

Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis

Thrombosis and haemostasis, 2018, Vol.118 (2), p.229-250

2018

Volltextzugriff (PDF)

Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.989-997

2015

Volltextzugriff (PDF)

The influence of corticosteroids on hemostasis in healthy subjects

Journal of thrombosis and haemostasis, 2016-04, Vol.14 (4), p.716-723

2016

Volltextzugriff (PDF)

Role of von Willebrand factor and ADAMTS‐13 in early brain injury after experimental subarachnoid hemorrhage

Journal of thrombosis and haemostasis, 2018-07, Vol.16 (7), p.1413-1422

2018

Volltextzugriff (PDF)

Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso‐occlusive crisis and steady state

Journal of thrombosis and haemostasis, 2017-07, Vol.15 (7), p.1392-1402

2017

Volltextzugriff (PDF)

Coagulation factor XI as a novel target for antithrombotic treatment

Journal of thrombosis and haemostasis, 2010-11, Vol.8 (11), p.2349-2357

2010

Volltextzugriff (PDF)

Tumor necrosis factor-α inhibition protects against endotoxin-induced endothelial glycocalyx perturbation

Atherosclerosis, 2009-01, Vol.202 (1), p.296-303

2009

Volltextzugriff (PDF)

Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time

Journal of thrombosis and haemostasis, 2011-08, Vol.9 (8), p.1657-1659

2011

Volltextzugriff (PDF)

A role for arginine‐12 in thrombin–thrombomodulin‐mediated activation of thrombin‐activatable fibrinolysis inhibitor

Journal of thrombosis and haemostasis, 2014-10, Vol.12 (10), p.1717-1725

2014

Volltextzugriff (PDF)

Effect of recombinant ADAMTS‐13 on microthrombosis and brain injury after experimental subarachnoid hemorrhage

Journal of thrombosis and haemostasis, 2014-06, Vol.12 (6), p.943-947

2014

Volltextzugriff (PDF)

Low miR-19b-1-5p expression in isolated platelets after aspirin use is related to aspirin insensitivity

International journal of cardiology, 2016-01, Vol.203, p.262-263

2016

Volltextzugriff (PDF)

New clues regarding the mysterious mechanism of activated thrombin‐activatable fibrinolysis inhibitor self‐destruction

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.1081-1083

2015

Volltextzugriff (PDF)

Use of an absorbable embolization material for reversible portal vein embolization in an experimental model

British journal of surgery, 2016-09, Vol.103 (10), p.1306-1315

2016

Volltextzugriff (PDF)

Selective modulation of thrombin‐activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin‐thrombomodulin complex using TAFI‐derived peptides

Journal of thrombosis and haemostasis, 2015-11, Vol.13 (11), p.2093-2101

2015

Volltextzugriff (PDF)

Lupus anticoagulants and the risk of a first episode of deep venous thrombosis

Journal of thrombosis and haemostasis, 2005-09, Vol.3 (9), p.1993-1997

2005

Volltextzugriff (PDF)

Association between protein C levels and mortality in patients with advanced prostate, lung and pancreatic cancer

Thrombosis research, 2017-06, Vol.154, p.1-6

2017

Volltextzugriff (PDF)

Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-09, Vol.24 (5), p.e312-e321

2018

Volltextzugriff (PDF)

Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke

Thrombosis research, 2015-08, Vol.136 (2), p.445-450

2015

Volltextzugriff (PDF)

1 – 25 von 354

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(350)
Mit Volltextzugriff
(285)

Publikationsform

Artikel
(354)

Sprache

Englisch
(354)

Erscheinungsjahr

n.n

Thema

Science & Technology
(319)
Life Sciences & Biomedicine
(314)
Humans
(262)
Hematology
(179)
Cardiovascular System & Cardiology
(148)
Male
(143)
Peripheral Vascular Disease
(139)
Female
(135)
Biological And Medical Sciences
(129)
Adult
(122)
Middle Aged
(97)
Medical Sciences
(95)
Animals
(88)
Coagulation
(65)
Fibrinolysis
(62)
Aged
(57)
Blood Coagulation
(56)
Fundamental And Applied Biological Sciences. Psychology
(55)
Mice
(47)
Molecular And Cellular Biology
(43)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Structure‐function relationships in thrombin‐activatable fibrinolysis inhibitor

Review: Viral infections and mechanisms of thrombosis and bleeding

Hyperglycemia: a prothrombotic factor?

Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease

In vivo increase in thrombin generation by four‐factor prothrombin complex concentrate in apixaban‐treated healthy volunteers

Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure

Factor XI promotes hemostasis in factor IX‐deficient mice

Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis

Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy

The influence of corticosteroids on hemostasis in healthy subjects

Role of von Willebrand factor and ADAMTS‐13 in early brain injury after experimental subarachnoid hemorrhage

Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso‐occlusive crisis and steady state

Coagulation factor XI as a novel target for antithrombotic treatment

Tumor necrosis factor-α inhibition protects against endotoxin-induced endothelial glycocalyx perturbation

Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time

A role for arginine‐12 in thrombin–thrombomodulin‐mediated activation of thrombin‐activatable fibrinolysis inhibitor

Effect of recombinant ADAMTS‐13 on microthrombosis and brain injury after experimental subarachnoid hemorrhage

Low miR-19b-1-5p expression in isolated platelets after aspirin use is related to aspirin insensitivity

New clues regarding the mysterious mechanism of activated thrombin‐activatable fibrinolysis inhibitor self‐destruction

Use of an absorbable embolization material for reversible portal vein embolization in an experimental model

Selective modulation of thrombin‐activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin‐thrombomodulin complex using TAFI‐derived peptides

Lupus anticoagulants and the risk of a first episode of deep venous thrombosis

Association between protein C levels and mortality in patients with advanced prostate, lung and pancreatic cancer

Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment

Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke

Suchergebnisse filtern